Signal integration during T lymphocyte activation and function: Lessons from the Wiskott-Aldrich syndrome

Frontiers in Immunology

Volumn 6, Issue FEB, 2015, Pages

  Cotta de Almeida, Vinicius ^a   Dupré, Loïc ^b,c,d   Guipouy, Delphine ^b,c,d   Vasconcelos, Zilton ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Université Paul Sabatier   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d CNRS   (France)

Author keywords

Actin cytoskeleton; Immunological synapse; Motility; Signaling; T lymphocytes; Transcription; Wiskott Aldrich syndrome

Indexed keywords

CASPASE 3; CD2 ANTIGEN; CD28 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; FAS LIGAND; G PROTEIN COUPLED RECEPTOR; GAMMA INTERFERON; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INTERLEUKIN 2; NATURAL KILLER CELL RECEPTOR NKG2D; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; PROLINE; PROTEIN BCL 2; PROTEIN CDC42; PROTEIN KINASE ZAP 70; PROTEIN SH2; PROTEIN SH3; PROTEIN TYROSINE KINASE; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; SERINE; SORTING NEXIN; STROMAL CELL DERIVED FACTOR 1; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR T BET; TYROSINE; UNINDEXED DRUG; WISKOTT ALDRICH SYNDROME PROTEIN;

ACTIN FILAMENT; AUTOIMMUNE DISEASE; CELL ADHESION; CELL DIFFERENTIATION; CELL MIGRATION; CYTOTOXICITY; HUMAN; IMMUNE DYSREGULATION; IMMUNOLOGICAL SYNAPSE; NEUTROPENIA; ONTOGENY; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; THROMBOCYTOPENIA; WISKOTT ALDRICH SYNDROME;

EID: 84926681613     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00047     Document Type: Review

References (104)

1. Albert MH, Notarangelo LD, Ochs HD. Clinical spectrum, pathophysiology and treatment of the Wiskott-Aldrich syndrome. Curr Opin Hematol (2011) 18:42-8. doi: 10.1097/MOH.0b013e32834114bc
2. Derry JM, Ochs HD, Francke U. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome. Cell (1994) 78:635-44. doi:10.1016/0092-8674(94)90528-2
3. Parolini O, Berardelli S, Riedl E, Bello-Fernandez C, Strobl H, Majdic O, et al. Expression of Wiskott-Aldrich syndrome protein (WASP) gene during hematopoietic differentiation. Blood (1997) 90:70-5.
4. Symons M, Derry JM, Karlak B, Jiang S, Lemahieu V, McCormick F, et al. Wiskott-Aldrich syndrome protein, a novel effector for the GTPase CDC42Hs, is implicated in actin polymerization. Cell (1996) 84:723-34. doi:10.1016/S0092-8674(00)81050-8
5. Machesky LM, Insall RH. Scar1 and the related Wiskott-Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex. Curr Biol (1998) 8:1347-56. doi:10.1016/S0960-9822(98)00015-3
6. Massaad MJ, Ramesh N, Geha RS. Wiskott-Aldrich syndrome: a comprehensive review. Ann N Y Acad Sci (2013) 1285:26-43. doi:10.1111/nyas.12049
7. Thrasher AJ, Burns SO. WASP: a key immunological multitasker. Nat Rev Immunol (2010) 10:182-92. doi:10.1038/nri2724
8. Higgs HN, Pollard TD. Activation by Cdc42 and PIP(2) of Wiskott-Aldrich syndrome protein (WASP) stimulates actin nucleation by Arp2/3 complex. J Cell Biol (2000) 150:1311-20. doi:10.1083/jcb.150.6.1311
9. Padrick SB, Rosen MK. Physical mechanisms of signal integration by WASP family proteins. Annu Rev Biochem (2010) 79:707-35. doi:10.1146/annurev.biochem.77.060407.135452
10. Ramesh N, Geha R. Recent advances in the biology of WASP and WIP. Immunol Res (2009) 44:99-111. doi:10.1007/s12026-008-8086-1
11. Sasahara Y, Rachid R, Byrne MJ, de la Fuente MA, Abraham RT, Ramesh N, et al. Mechanism of recruitment of WASP to the immunological synapse and of its activation following TCR ligation. Mol Cell (2002) 10:1269-81. doi:10.1016/S1097-2765(02)00728-1
12. de la Fuente MA, Sasahara Y, Calamito M, Anton IM, Elkhal A, Gallego MD, et al. WIP is a chaperone for Wiskott-Aldrich syndrome protein (WASP). Proc Natl Acad Sci U S A (2007) 104:926-31. doi:10.1073/pnas.0610275104
13. Torres E, Rosen MK. Protein-tyrosine kinase and GTPase signals cooperate to phosphorylate and activate Wiskott-Aldrich syndrome protein (WASP)/neuronal WASP. J Biol Chem (2006) 281:3513-20. doi:10.1074/jbc.M509416200
14. Badour K, Zhang J, Shi F, Leng Y, Collins M, Siminovitch KA. Fyn and PTP-PEST-mediated regulation of Wiskott-Aldrich syndrome protein (WASP) tyrosine phosphorylation is required for coupling T cell antigen receptor engagement to WASP effector function and T cell activation. J Exp Med (2004) 199:99-112. doi:10.1084/jem.20030976
15. Ancliff PJ, Blundell MP, Cory GO, Calle Y, Worth A, Kempski H, et al. Two novel activating mutations in the Wiskott-Aldrich syndrome protein result in congenital neutropenia. Blood (2006) 108:2182-9. doi:10.1182/blood-2006-01-010249
16. Devriendt K, Kim AS, Mathijs G, Frints SG, Schwartz M, Van Den Oord JJ, et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet (2001) 27:313-7. doi:10.1038/85886
17. Westerberg LS, Meelu P, Baptista M, Eston MA, Adamovich DA, Cotta-de-Almeida V, et al. Activating WASP mutations associated with X-linked neutropenia result in enhanced actin polymerization, altered cytoskeletal responses, and genomic instability in lymphocytes. J Exp Med (2010) 207:1145-52. doi:10.1084/jem.20091245
18. Padrick SB, Doolittle LK, Brautigam CA, King DS, Rosen MK. Arp2/3 complex is bound and activated by two WASP proteins. Proc Natl Acad Sci U S A (2011) 108:E472-9. doi:10.1073/pnas.1100236108
19. Smith BA, Daugherty-Clarke K, Goode BL, Gelles J. Pathway of actin filament branch formation by Arp2/3 complex revealed by single-molecule imaging. Proc Natl Acad Sci U S A (2013) 110:1285-90. doi:10.1073/pnas.1211164110
20. Helgeson LA, Nolen BJ. Mechanism of synergistic activation of Arp2/3 complex by cortactin and N-WASP. Elife (2013) 2:e00884. doi:10.7554/eLife.00884
21. Watanabe Y, Sasahara Y, Ramesh N, Massaad MJ, Yeng Looi C, Kumaki S, et al. T-cell receptor ligation causes Wiskott-Aldrich syndrome protein degradation and F-actin assembly downregulation. J Allergy Clin Immunol (2013) 132:648-55.e1. doi:10.1016/j.jaci.2013.03.046
22. Reicher B, Joseph N, David A, Pauker MH, Perl O, Barda-Saad M. Ubiquitylation-dependent negative regulation of WASP is essential for actin cytoskeleton dynamics. Mol Cell Biol (2012) 32:3153-63. doi:10.1128/MCB.00161-12
23. Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, et al. Mutations of the Wiskott-Aldrich syndrome protein (WASP): hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood (2004) 104:4010-9. doi:10.1182/blood-2003-05-1592
24. Lanzi G, Moratto D, Vairo D, Masneri S, Delmonte O, Paganini T, et al. A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP. J Exp Med (2012) 209:29-34. doi:10.1084/jem.20110896
25. Labno CM, Lewis CM, You D, Leung DW, Takesono A, Kamberos N, et al. Itk functions to control actin polymerization at the immune synapse through localized activation of Cdc42 and WASP. Curr Biol (2003) 13:1619-24. doi:10.1016/j.cub.2003.08.005
26. Zeng R, Cannon JL, Abraham RT, Way M, Billadeau DD, Bubeck-Wardenberg J, et al. SLP-76 coordinates Nck-dependent Wiskott-Aldrich syndrome protein recruitment with Vav-1/Cdc42-dependent Wiskott-Aldrich syndrome protein activation at the T cell-APC contact site. J Immunol (2003) 171:1360-8. doi:10.4049/jimmunol.171.3.1360
27. Dupré L, Aiuti A, Trifari S, Martino S, Saracco P, Bordignon C, et al. Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity (2002) 17:157-66. doi:10.1016/S1074-7613(02)00360-6
28. Torres E, Rosen MK. Contingent phosphorylation/dephosphorylation provides a mechanism of molecular memory in WASP. Mol Cell (2003) 11:1215-27. doi:10.1016/S1097-2765(03)00139-4
29. Simonson WT, Franco SJ, Huttenlocher A. Talin1 regulates TCR-mediated LFA-1 function. J Immunol (2006) 177:7707-14. doi:10.4049/jimmunol.177.11.7707
30. Michel F, Mangino G, Attal-Bonnefoy G, Tuosto L, Alcover A, Roumier A, et al. CD28 utilizes Vav-1 to enhance TCR-proximal signaling and NF-AT activation. J Immunol (2000) 165:3820-9. doi:10.4049/jimmunol.165.7.3820
31. Badour K, Zhang J, Shi F, McGavin MKH, Rampersad V, Hardy LA, et al. The Wiskott-Aldrich syndrome protein acts downstream of CD2 and the CD2AP and PSTPIP1 adaptors to promote formation of the immunological synapse. Immunity (2003) 18:141-54. doi:10.1016/S1074-7613(02)00516-2
32. Vicente-Manzanares M, Cruz-Adalia A, Martin-Cofreces NB, Cabrero JR, Dosil M, Alvarado-Sanchez B, et al. Control of lymphocyte shape and the chemotactic response by the GTP exchange factor Vav. Blood (2005) 105:3026-34. doi:10.1182/blood-2004-07-2925
33. Gallego MD, de la Fuente MA, Anton IM, Snapper S, Fuhlbrigge R, Geha RS. WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1alpha. Int Immunol (2006) 18:221-32. doi:10.1093/intimm/dxh310
34. Chen B, Brinkmann K, Chen Z, Pak CW, Liao Y, Shi S, et al. The WAVE regulatory complex links diverse receptors to the actin cytoskeleton. Cell (2014) 156:195-207. doi:10.1016/j.cell.2013.11.048
35. Serrano-Pertierra E, Cernuda-Morollon E, Lopez-Larrea C. NKG2D-and CD28-mediated costimulation regulate CD8+ T cell chemotaxis through different mechanisms: the role of Cdc42/N-WASP. J Leukoc Biol (2014) 95:487-95. doi:10.1189/jlb.0613316
36. Burkhardt JK, Carrizosa E, Shaffer MH. The actin cytoskeleton in T cell activation. Annu Rev Immunol (2008) 26:233-59. doi:10.1146/annurev.immunol.26.021607.090347
37. Dustin ML, Groves JT. Receptor signaling clusters in the immune synapse. Annu Rev Biophys (2012) 41:543-56. doi:10.1146/annurev-biophys-042910-155238
38. Barda-Saad M, Braiman A, Titerence R, Bunnell SC, Barr VA, Samelson LE. Dynamic molecular interactions linking the T cell antigen receptor to the actin cytoskeleton. Nat Immunol (2005) 6:80-9. doi:10.1038/ni1143
39. Varma R, Campi G, Yokosuka T, Saito T, Dustin ML. T cell receptor-proximal signals are sustained in peripheral microclusters and terminated in the central supramolecular activation cluster. Immunity (2006) 25:117-27. doi:10.1016/j.immuni.2006.04.010
40. Calvez R, Lafouresse F, De Meester J, Galy A, Valitutti S, Dupré L. The Wiskott-Aldrich syndrome protein permits assembly of a focused immunological synapse enabling sustained T-cell receptor signaling. Haematologica (2011) 96:1415-23. doi:10.3324/haematol.2011.040204
41. Sims TN, Soos TJ, Xenias HS, Dubin-Thaler B, Hofman JM, Waite JC, et al. Opposing effects of PKCtheta and WASP on symmetry breaking and relocation of the immunological synapse. Cell (2007) 129:773-85. doi:10.1016/j.cell.2007.03.037
42. De Meester J, Calvez R, Valitutti S, Dupré L. The Wiskott-Aldrich syndrome protein regulates CTL cytotoxicity and is required for efficient killing of B cell lymphoma targets. J Leukoc Biol (2010) 88:1031-40. doi:10.1189/jlb.0410197
43. Morales-Tirado V, Johannson S, Hanson E, Howell A, Zhang J, Siminovitch KA, et al. Cutting edge: selective requirement for the Wiskott-Aldrich syndrome protein in cytokine, but not chemokine, secretion by CD4+ T cells. J Immunol (2004) 173:726-30. doi:10.4049/jimmunol.173.2.726
44. Rivas FV, O'Keefe JP, Alegre ML, Gajewski TF. Actin cytoskeleton regulates calcium dynamics and NFAT nuclear duration. Mol Cell Biol (2004) 24:1628-39. doi:10.1128/MCB.24.4.1628-1639.2004
45. Badour K, Zhang J, Siminovitch KA. Involvement of the Wiskott-Aldrich syndrome protein and other actin regulatory adaptors in T cell activation. Semin Immunol (2004) 16:395-407. doi:10.1016/j.smim.2004.08.019
46. Cannon JL, Burkhardt JK. Differential roles for Wiskott-Aldrich syndrome protein in immune synapse formation and IL-2 production. J Immunol (2004) 173:1658-62. doi:10.4049/jimmunol.173.3.1658
47. Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, Germain RN. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature (2006) 440:890-5. doi:10.1038/nature04651
48. Snapper SB, Meelu P, Nguyen D, Stockton BM, Bozza P, Alt FW, et al. WASP deficiency leads to global defects of directed leukocyte migration in vitro and in vivo. J Leukoc Biol (2005) 77:993-8. doi:10.1189/jlb.0804444
49. Trifari S, Sitia G, Aiuti A, Scaramuzza S, Marangoni F, Guidotti LG, et al. Defective Th1 cytokine gene transcription in CD4+ and CD8+ T cells from Wiskott-Aldrich syndrome patients. J Immunol 177(2006):7451-61. doi:10.4049/jimmunol.177.10.7451
50. Taylor MD, Sadhukhan S, Kottangada P, Ramgopal A, Sarkar K, D'Silva S, et al. Nuclear role of WASP in the pathogenesis of dysregulated TH1 immunity in human Wiskott-Aldrich syndrome. Sci Transl Med (2010) 2:37ra44. doi:10.1126/scitranslmed.3000813
51. Sadhukhan S, Sarkar K, Taylor M, Candotti F, Vyas YM. Nuclear role of WASP in gene transcription is uncoupled from its ARP2/3-dependent cytoplasmic role in actin polymerization. J Immunol (2014) 193:150-60. doi:10.4049/jimmunol.1302923
52. Algeciras-Schimnich A, Shen L, Barnhart BC, Murmann AE, Burkhardt JK, Peter ME. Molecular ordering of the initial signaling events of CD95. Mol Cell Biol (2002) 22:207-20. doi:10.1128/MCB.22.1.207-220.2002
53. Rawlings SL, Crooks GM, Bockstoce D, Barsky LW, Parkman R, Weinberg KI. Spontaneous apoptosis in lymphocytes from patients with Wiskott-Aldrich syndrome: correlation of accelerated cell death and attenuated bcl-2 expression. Blood (1999) 94:3872-82.
54. Rengan R, Ochs HD, Sweet LI, Keil ML, Gunning WT, Lachant NA, et al. Actin cytoskeletal function is spared, but apoptosis is increased, in WAS patient hematopoietic cells. Blood (2000) 95:1283-92.
55. Nikolov NP, Shimizu M, Cleland S, Bailey D, Aoki J, Strom T, et al. Systemic autoimmunity and defective Fas ligand secretion in the absence of the Wiskott-Aldrich syndrome protein. Blood (2010) 116:740-7. doi:10.1182/blood-2009-08-237560
56. McGavin MK, Badour K, Hardy LA, Kubiseski TJ, Zhang J, Siminovitch KA. The intersectin 2 adaptor links Wiskott Aldrich syndrome protein (WASP)-mediated actin polymerization to T cell antigen receptor endocytosis. J Exp Med (2001) 194:1777-87. doi:10.1084/jem.194.12.1777
57. Badour K, McGavin MK, Zhang J, Freeman S, Vieira C, Filipp D, et al. Interaction of the Wiskott-Aldrich syndrome protein with sorting nexin 9 is required for CD28 endocytosis and cosignaling in T cells. Proc Natl Acad Sci U S A (2007) 104:1593-8. doi:10.1073/pnas.0610543104
58. Lafouresse F, Cotta-de-Almeida V, Malet-Engra G, Galy A, Valitutti S, Dupré L. Wiskott-Aldrich syndrome protein controls antigen-presenting cell-driven CD4+ T-cell motility by regulating adhesion to intercellular adhesion molecule-1. Immunology (2012) 137:183-96. doi:10.1111/j.1365-2567.2012.03620.x
59. Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol (2006) 117:725-38. doi:10.1016/j.jaci.2006.02.005
60. Wolff JA. Wiskott-Aldrich syndrome: clinical, immunologic, and pathologic observations. J Pediatr (1967) 70:221-32. doi:10.1016/S0022-3476(67)80417-7
61. Park JY, Kob M, Prodeus AP, Rosen FS, Shcherbina A, Remold-O'Donnell E. Early deficit of lymphocytes in Wiskott-Aldrich syndrome: possible role of WASP in human lymphocyte maturation. Clin Exp Immunol (2004) 136:104-10. doi:10.1111/j.1365-2249.2004.02409.x
62. Ochs HD, Slichter SJ, Harker LA, Von Behrens WE, Clark RA, Wedgwood RJ. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. Blood (1980) 55:243-52.
63. Braun CJ, Boztug K, Paruzynski A, Witzel M, Schwarzer A, Rothe M, et al. Gene therapy for Wiskott-Aldrich syndrome-long-term efficacy and genotoxicity. Sci Transl Med (2014) 6:227ra33. doi:10.1126/scitranslmed.3007280
64. O'Connell AE, Volpi S, Dobbs K, Fiorini C, Tsitsikov E, de Boer H, et al. Next generation sequencing reveals skewing of the T and B cell receptor repertoires in patients with Wiskott-Aldrich syndrome. Front Immunol (2014) 5:340. doi:10.3389/fimmu.2014.00340
65. Wu J, Liu D, Tu W, Song W, Zhao X. T-cell receptor diversity is selectively skewed in T-cell populations of patients with Wiskott-Aldrich syndrome. J Allergy Clin Immunol (2015) 135(1):209-16.e8. doi:10.1016/j.jaci.2014.06.025
66. Wada T, Schurman SH, Garabedian EK, Yachie A, Candotti F. Analysis of T-cell repertoire diversity in Wiskott-Aldrich syndrome. Blood (2005) 106:3895-7. doi:10.1182/blood-2005-06-2336
67. Wada T, Konno A, Schurman SH, Garabedian EK, Anderson SM, Kirby M, et al. Second-site mutation in the Wiskott-Aldrich syndrome (WAS) protein gene causes somatic mosaicism in two WAS siblings. J Clin Invest (2003) 111:1389-97. doi:10.1172/JCI200315485
68. Stewart DM, Candotti F, Nelson DL. The phenomenon of spontaneous genetic reversions in the Wiskott-Aldrich syndrome: a report of the workshop of the ESID Genetics Working Party at the XIIth Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary October 4-7, 2006. J Clin Immunol (2007) 27:634-9. doi:10.1007/s10875-007-9121-z
69. Ariga T, Kondoh T, Yamaguchi K, Yamada M, Sasaki S, Nelson DL, et al. Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome. J Immunol 166(2001):5245-9. doi:10.4049/jimmunol.166.8.5245
70. Trifari S, Scaramuzza S, Catucci M, Ponzoni M, Mollica L, Chiesa R, et al., Revertant T lymphocytes in a patient with Wiskott-Aldrich syndrome: analysis of function and distribution in lymphoid organs. J Allergy Clin Immunol (2010) 125:439-48.e8. doi:10.1016/j.jaci.2009.11.034
71. Wada T, Schurman SH, Otsu M, Garabedian EK, Ochs HD, Nelson DL, et al. Somatic mosaicism in Wiskott-Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism. Proc Natl Acad Sci U S A (2001) 98:8697-702. doi:10.1073/pnas.151260498
72. Davis BR, Candotti F. Revertant somatic mosaicism in the Wiskott-Aldrich syndrome. Immunol Res (2009) 44:127-31. doi:10.1007/s12026-008-8091-4
73. Haddad E, Zugaza JL, Louache F, Debili N, Crouin C, Schwarz K, et al. The interaction between Cdc42 and WASP is required for SDF-1-induced T-lymphocyte chemotaxis. Blood (2001) 97:33-8. doi:10.1182/blood.V97.1.33
74. Molina IJ, Sancho J, Terhorst C, Rosen FS, Remold-O'Donnell E. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. J Immunol (1993) 151:4383-90.
75. Cianferoni A, Massaad M, Feske S, de la Fuente MA, Gallego L, Ramesh N, et al. Defective nuclear translocation of nuclear factor of activated T cells and extracellular signal-regulated kinase underlies deficient IL-2 gene expression in Wiskott-Aldrich syndrome. J Allergy Clin Immunol (2005) 116:1364-71. doi:10.1016/j.jaci.2005.09.006
76. Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, et al. Clinical course of patients with WASP gene mutations. Blood (2004) 103:456-64. doi:10.1182/blood-2003-05-1480
77. Azuma H, Oshima M, Ito K, Okuno A, Kawabata I, Banba K, et al. Impaired interleukin-2 production in T-cells from a patient with Wiskott-Aldrich syndrome: basis of clinical effect of interleukin-2 replacement therapy. Eur J Pediatr (2000) 159:633-4. doi:10.1007/PL00008395
78. Adriani M, Aoki J, Horai R, Thornton AM, Konno A, Kirby M, et al. Impaired in vitro regulatory T cell function associated with Wiskott-Aldrich syndrome. Clin Immunol (2007) 124:41-8. doi:10.1016/j.clim.2007.02.001
79. Humblet-Baron S, Sather B, Anover S, Becker-Herman S, Kasprowicz DJ, Khim S, et al. Wiskott-Aldrich syndrome protein is required for regulatory T cell homeostasis. J Clin Invest (2007) 117:407-18. doi:10.1172/JCI29539
80. Maillard MH, Cotta-de-Almeida V, Takeshima F, Nguyen DD, Michetti P, Nagler C, et al. The Wiskott-Aldrich syndrome protein is required for the function of CD4(+)CD25(+)Foxp3(+) regulatory T cells. J Exp Med (2007) 204:381-91. doi:10.1084/jem.20061338
81. Marangoni F, Trifari S, Scaramuzza S, Panaroni C, Martino S, Notarangelo LD, et al. WASP regulates suppressor activity of human and murine CD4(+)CD25(+)FOXP3(+) natural regulatory T cells. J Exp Med (2007) 204:369-80. doi:10.1084/jem.20061334
82. Dupuis-Girod S, Medioni J, Haddad E, Quartier P, Cavazzana-Calvo M, Le Deist F, et al. Autoimmunity in Wiskott-Aldrich syndrome: risk factors, clinical features, and outcome in a single-center cohort of 55 patients. Pediatrics (2003) 111:e622-7. doi:10.1542/peds.111.5.e622
83. Westerberg LS, de la Fuente MA, Wermeling F, Ochs HD, Karlsson MC, Snapper SB, et al. WASP confers selective advantage for specific hematopoietic cell populations and serves a unique role in marginal zone B-cell homeo-stasis and function. Blood (2008) 112:4139-47. doi:10.1182/blood-2008-02-140715
84. Meyer-Bahlburg A, Becker-Herman S, Humblet-Baron S, Khim S, Weber M, Bouma G, et al. Wiskott-Aldrich syndrome protein deficiency in B cells results in impaired peripheral homeostasis. Blood (2008) 112:4158-69. doi:10.1182/blood-2008-02-140814
85. Adriani M, Jones KA, Uchiyama T, Kirby MR, Silvin C, Anderson SM, et al. Defective inhibition of B-cell proliferation by Wiskott-Aldrich syndrome protein-deficient regulatory T cells. Blood (2011) 117:6608-11. doi:10.1182/blood-2010-12-322834
86. Strom TS, Turner SJ, Andreansky S, Liu H, Doherty PC, Srivastava DK, et al. Defects in T-cell-mediated immunity to influenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells. Blood (2003) 102:3108-16. doi:10.1182/blood-2002-11-3489
87. Andreansky S, Liu H, Turner S, McCullers JA, Lang R, Rutschman R, et al. WASP-mice exhibit defective immune responses to influenza A virus, Streptococcus pneumoniae, and Mycobacterium bovis BCG. Exp Hematol (2005) 33:443-51. doi:10.1016/j.exphem.2004.12.006
88. Orange JS, Roy-Ghanta S, Mace EM, Maru S, Rak GD, Sanborn KB, et al. IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASP-independent human NK cell function. J Clin Invest (2011) 121:1535-48. doi:10.1172/JCI44862
89. Gismondi A, Cifaldi L, Mazza C, Giliani S, Parolini S, Morrone S, et al. Impaired natural and CD16-mediated NK cell cytotoxicity in patients with WAS and XLT: ability of IL-2 to correct NK cell functional defect. Blood (2004) 104:436-43. doi:10.1182/blood-2003-07-2621
90. Orange JS, Harris KE, Andzelm MM, Valter MM, Geha RS, Strominger JL. The mature activating natural killer cell immunologic synapse is formed in distinct stages. Proc Natl Acad Sci U S A (2003) 100:14151-6. doi:10.1073/pnas.1835830100
91. Krzewski K, Chen X, Orange JS, Strominger JL. Formation of a WIP-, WASP-, actin-, and myosin IIA-containing multiprotein complex in activated NK cells and its alteration by KIR inhibitory signaling. J Cell Biol (2006) 173:121-32. doi:10.1083/jcb.200509076
92. Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr (1994) 125:876-85. doi:10.1016/S0022-3476(05)82002-5
93. Lang PA, Shaabani N, Borkens S, Honke N, Scheu S, Booth S, et al. Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency. J Allergy Clin Immunol (2013) 131:815-24. doi:10.1016/j.jaci.2012.08.050
94. Locci M, Draghici E, Marangoni F, Bosticardo M, Catucci M, Aiuti A, et al. The Wiskott-Aldrich syndrome protein is required for iNKT cell maturation and function. J Exp Med (2009) 206:735-42. doi:10.1084/jem.20081773
95. Astrakhan A, Ochs HD, Rawlings DJ. Wiskott-Aldrich syndrome protein is required for homeostasis and function of invariant NKT cells. J Immunol (2009) 182:7370-80. doi:10.4049/jimmunol.0804256
96. Morio T, Takase K, Okawa H, Oguchi M, Kanbara M, Hiruma F, et al. The increase of non-MHC-restricted cytotoxic cells (gamma/delta-TCR-bearing T cells or NK cells) and the abnormal differentiation of B cells in Wiskott-Aldrich syndrome. Clin Immunol Immunopathol (1989) 52:279-90. doi:10.1016/0090-1229(89)90179-7
97. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature (2006) 441:235-8. doi:10.1038/nature04753
98. Bouma G, Carter NA, Recher M, Malinova D, Adriani M, Notarangelo LD, et al. Exacerbated experimental arthritis in Wiskott-Aldrich syndrome protein deficiency: modulatory role of regulatory B cells. Eur J Immunol (2014) 44:2692-702. doi:10.1002/eji.201344245
99. King C, Tangye SG, Mackay CR. T follicular helper (TFH) cells in normal and dysregulated immune responses. Annu Rev Immunol (2008) 26:741-66. doi:10.1146/annurev.immunol.26.021607.090344
100. Bouma G, Burns S, Thrasher AJ. Impaired T-cell priming in vivo resulting from dysfunction of WASP-deficient dendritic cells. Blood (2007) 110:4278-84. doi:10.1182/blood-2007-06-096875
101. Bouma G, Mendoza-Naranjo A, Blundell MP, de Falco E, Parsley KL, Burns SO, et al. Cytoskeletal remodeling mediated by WASP in dendritic cells is necessary for normal immune synapse formation and T-cell priming. Blood (2011) 118:2492-501. doi:10.1182/blood-2011-03-340265
102. Dupre L, Marangoni F, Scaramuzza S, Trifari S, Hernandez RJ, Aiuti A, et al. Efficacy of gene therapy for Wiskott-Aldrich syndrome using a WAS promoter/cDNA-containing lentiviral vector and nonlethal irradiation. Hum Gene Ther (2006) 17:303-13. doi:10.1089/hum.2006.17.303
103. Dupre L, Trifari S, Follenzi A, Marangoni F, Lain de Lera T, Bernad A, et al. Lentiviral vector-mediated gene transfer in T cells from Wiskott-Aldrich syndrome patients leads to functional correction. Mol Ther (2004) 10:903-15. doi:10.1016/j.ymthe.2004.08.008
104. Aiuti A, Biasco L, Scaramuzza S, Ferrua F, Cicalese MP, Baricordi C, et al. Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science (2013) 341:1233151. doi:10.1126/science.1233151